
zzso zzso patients can experience zzso zzso which may not respond to zzso zzso zzso is an zzso zzso zzso that can reverse zzso zzso without affecting zzso Published literature on the use of zzso in children is very zzso This retrospective review describes the effectiveness and safety of zzso for zzso zzso in pediatric zzso zzso 

A retrospective review of health records was conducted for pediatric zzso zzso who were prescribed zzso between May 2008 and September 2012 at The Hospital for Sick zzso zzso clinical, zzso and safety data were collected, zzso zzso zzso and zzso dosing and zzso 

Fifteen patients zzso age: 14 years, zzso zzso zzso received zzso 12 received a single dose while three received multiple zzso At the time of zzso administration, patients were receiving a median oral zzso dose equivalent of zzso zzso zzso and had not had any zzso movements for several days despite treatment with multiple zzso zzso was given at a mean dose of zzso zzso zzso as a subcutaneous zzso After 14 of 19 doses zzso patients had a zzso movement within zzso Three patients had documented mild gastrointestinal upset following zzso zzso None reported a reduction of pain control or zzso withdrawal zzso 

This case series suggests that zzso is safe and may be effective when given zzso as a zzso single dose to pediatric zzso patients with zzso zzso 

